Final results of first European phase II trial of intravenous cetuximab (Cet) and hepatic artery infusion of irinotecan, 5-fluorouracil, and oxaliplatin in patients (pts) with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) after systemic treatment failure (OPTILIV, NCT00852228)

Abstract only 466 Background: Multiple, large and bilateral LM-CRC can be downsized with chemotherapy (chemo) and resected with curative intent in ~15% pts (Adam et al. 2004). The complete resection rate (R0+R1) may be increased with Cet addition, triplet chemotherapy, chronomodulated delivery (Chro...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical oncology 2013-02, Vol.31 (4_suppl), p.466-466
Hauptverfasser:	Levi, Francis, Boige, Valerie, Hebbar, Mohamed, Smith, Denis, Lepère, Céline, Focan, C. N. J., Guimbaud, Rosine, Carvalho, Carlos, Tumolo, Salvatore, Innominato, Pasquale F., Ajavon, Yves, Truant, Stephanie, Castaing, Denis, De Baere, Thierry, Kunstlinger, Francis, Karaboué, Abdoulaye, Bouchahda, Mohamed, Rougier, Philippe R, Adam, Rene, Ducreux, Michel
Format:	Artikel
Sprache:	eng
Schlagworte:	Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!